IP Verse

Becton Dickinson Infusion Therapy Systems Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Becton Dickinson Infusion Therapy Systems Inc. opposed by its competitors

Patent:
EP2325643
Grant Date:
Dec 1, 2021
Title:
Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xv
Oppositions:
1
Patent:
EP2322930
Grant Date:
Jul 14, 2021
Title:
Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xiv
Oppositions:
1
Patent:
EP2325647
Grant Date:
Jul 14, 2021
Title:
Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xx
Oppositions:
1
Patent:
EP2325644
Grant Date:
Jul 29, 2020
Title:
Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xii
Oppositions:
2
Patent:
EP2325645
Grant Date:
Jul 29, 2020
Title:
Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xiii
Oppositions:
2
Patent:
EP2325646
Grant Date:
Jan 30, 2019
Title:
Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xvii
Oppositions:
1

Competitors of Becton Dickinson Infusion Therapy Systems Inc.

BECKMAN COULTER, INC.

HERTIN UND PARTNER RECHTS- UND PATENTANWALTE PARTG MBB

Want to track Becton Dickinson Infusion Therapy Systems Inc.?

Feel free to send us a message here and we will get back to you